Consolidated Cash Flow Statement

for the year ended March 31, 2021

in ‘000s
    Year ended
Year ended
Cash flow from/(used in) operating activities      
Profit/(loss) before taxes   240,486,799 169,294,471
Adjustments for:      
Depreciation and amortisation   14,713,701 13,696,381
Net (appreciation)/depreciation on investments1   (22,476,697) 21,809,159
Provision in respect of non-performing and other assets   110,315,149 89,627,398
General provision for standard assets   49,069,050 34,439,929
Provision for contingencies & others   6,339,684 7,936,906
(Profit)/loss on sale of fixed assets   63,424 (1,450)
Employees stock options grants   77,611 114,130
  (i) 398,588,721 336,916,924
Adjustments for:      
(Increase)/decrease in investments   90,478,662 (315,313,149)
(Increase)/decrease in advances   (968,932,842) (692,434,146)
Increase/(decrease) in deposits   1,591,555,570 1,194,675,249
(Increase)/decrease in other assets   4,276,368 24,560,834
Increase/(decrease) in other liabilities and provisions   302,522,352 271,160,685
  (ii) 1,019,900,110 482,649,473
Refund/(payment) of direct taxes (iii) (38,335,863) (23,918,931)
Net cash flow from/(used in) operating activities (i)+(ii)+(iii) (A) 1,380,152,968 795,647,466
Cash flow from/(used in) investing activities      
Purchase of fixed assets   (16,882,058) (18,734,522)
Proceeds from sale of fixed assets   121,649 255,374
(Purchase)/sale of held to maturity securities   (613,108,700) (404,605,131)
Net cash flow from/(used in) investing activities (B) (629,869,109) (423,084,279)
Cash flow from/(used in) financing activities      
Proceeds from issue of share capital (including ESOPs)   154,600,321 5,493,213
Proceeds from long-term borrowings   294,215,131 366,114,451
Repayment of long-term borrowings   (527,734,115) (520,006,249)
Net proceeds/(repayment) of short-term borrowings   (467,749,038) 187,184,210
Dividend and dividend tax paid   - (8,863,792)
Net cash flow from/(used in) financing activities (C) (546,667,701) 29,921,833
Effect of exchange fluctuation on translation reserve (D) (6,440,073) 2,135,244
Net increase/(decrease) in cash and cash equivalents (A) + (B) + (C) + (D)   197,176,085 404,620,264
Cash and cash equivalents at beginning of the year   1,278,529,217 873,908,953
Cash and cash equivalents at end of the year   1,475,705,302 1,278,529,217

1. For the year ended March 31, 2021, includes gain on sale of a part of equity investment in the subsidiaries, ICICI Lombard General Insurance Company Limited, ICICI Prudential Life Insurance Company Limited and ICICI Securities Limited.

2. Cash and cash equivalents include cash in hand, balances with RBI, balances with other banks and money at call and short notice.

As per our Report of even date.

For Walker Chandiok & Co LLP
Chartered Accountants
ICAI Firm Registration no.:

Sudhir N. Pillai
Membership no.: 105782

For and on behalf of the Board of Directors

Girish Chandra Chaturvedi

Vishakha Mulye
Executive Director

Rakesh Jha
Group Chief Financial Officer

Uday M. Chitale

Anup Bagchi
Executive Director

Ranganath Athreya
Company Secretary

Sandeep Bakhshi
Managing Director & CEO

Sandeep Batra
Executive Director

Rajendra Khandelwal
Chief Accountant

April 24, 2021